Clinical Trial: A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07672756) titled 'A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU)' on June 17.

Brief Summary: The primary objective of this clinical trial is to evaluate the safety and tolerability of single and multiple administrations of PL54 in patients aged 18-55 years. The key questions it aims to answer include:

How safe and tolerable is PL54 in PKU patients following single and multiple administrations?

Researchers will compare the safety and tolerability profiles between single and multiple dosing regimens to assess PL54.

Participants will be required to:

Phase Ia (Single Administration):

Re...